Vanguard Group Inc. Buys 1,604,040 Shares of Kenvue Inc. $KVUE

Vanguard Group Inc. boosted its stake in shares of Kenvue Inc. (NYSE:KVUE - Free Report) by 0.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 234,951,484 shares of the company's stock after purchasing an additional 1,604,040 shares during the quarter. Vanguard Group Inc. owned about 12.26% of Kenvue worth $4,052,913,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors also recently added to or reduced their stakes in the stock. Concurrent Investment Advisors LLC purchased a new stake in Kenvue in the fourth quarter valued at about $225,000. Calamos Advisors LLC purchased a new stake in Kenvue in the fourth quarter valued at about $46,575,000. Teacher Retirement System of Texas raised its stake in Kenvue by 284.3% in the fourth quarter. Teacher Retirement System of Texas now owns 1,138,508 shares of the company's stock valued at $19,639,000 after buying an additional 842,252 shares during the last quarter. West Michigan Advisors LLC raised its stake in Kenvue by 5.0% in the fourth quarter. West Michigan Advisors LLC now owns 140,446 shares of the company's stock valued at $2,423,000 after buying an additional 6,699 shares during the last quarter. Finally, Villere ST Denis J & Co. LLC raised its stake in Kenvue by 15.3% in the fourth quarter. Villere ST Denis J & Co. LLC now owns 786,138 shares of the company's stock valued at $13,561,000 after buying an additional 104,598 shares during the last quarter. Institutional investors own 97.64% of the company's stock.

Analyst Upgrades and Downgrades

KVUE has been the subject of several research analyst reports. Argus upgraded Kenvue to a "hold" rating in a research note on Friday, March 6th. Weiss Ratings restated a "hold (c-)" rating on shares of Kenvue in a research note on Wednesday, April 8th. Canaccord Genuity Group raised their price objective on Kenvue from $17.00 to $18.00 and gave the stock a "hold" rating in a research note on Wednesday, February 18th. UBS Group dropped their target price on Kenvue from $19.00 to $18.00 and set a "neutral" rating on the stock in a report on Tuesday, April 7th. Finally, Jefferies Financial Group lowered Kenvue from a "buy" rating to a "hold" rating and dropped their target price for the stock from $23.00 to $18.00 in a report on Friday, January 30th. Three investment analysts have rated the stock with a Buy rating and thirteen have issued a Hold rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Hold" and an average target price of $19.33.

Kenvue Stock Up 0.2%

Kenvue stock opened at $17.53 on Tuesday. The company has a quick ratio of 0.68, a current ratio of 0.96 and a debt-to-equity ratio of 0.66. Kenvue Inc. has a 52 week low of $14.02 and a 52 week high of $25.17. The business's 50-day moving average price is $17.80 and its 200 day moving average price is $17.16. The firm has a market cap of $33.65 billion, a price-to-earnings ratio of 22.76, a price-to-earnings-growth ratio of 3.97 and a beta of 0.61.

Kenvue (NYSE:KVUE - Get Free Report) last issued its quarterly earnings data on Tuesday, February 17th. The company reported $0.27 EPS for the quarter, beating the consensus estimate of $0.22 by $0.05. Kenvue had a return on equity of 19.72% and a net margin of 9.72%.The company had revenue of $3.78 billion for the quarter, compared to analyst estimates of $3.68 billion. During the same period last year, the company earned $0.26 earnings per share. Kenvue's quarterly revenue was up 3.2% compared to the same quarter last year. As a group, sell-side analysts anticipate that Kenvue Inc. will post 1.1 earnings per share for the current year.

Kenvue Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, February 25th. Stockholders of record on Wednesday, February 11th were paid a $0.2075 dividend. The ex-dividend date of this dividend was Wednesday, February 11th. This represents a $0.83 dividend on an annualized basis and a dividend yield of 4.7%. Kenvue's payout ratio is currently 107.79%.

Kenvue Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.